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ABSTRACT: The [3,5,5,7] tetracyclic skeleton of echinopines has been stereo-
selectively accessed through a gold(I)-catalyzed alkoxycyclization of cyclopropyl-
tethered 1,6-enynes. The key bicyclo[4.2.1]nonane core of the enyne precursors was
readily assembled by means of a Co-catalyzed [6 + 2] cycloaddition. Furthermore, the
attempted alkoxycyclization of 1,5-enyne substrates revealed an uncovered cyclopropyl
rearrangement that gives rise to [3,6,5,7] tetracyclic structures.
■ INTRODUCTION
Echinopines A and B (1 and 2) were isolated in 2008 from the
roots of Echinops spinosus and feature an unprecedented
[3,5,5,7]-membered-ring tetracyclic skeleton (Scheme 1),
which probably originates biosynthetically from a guaiane
precursor.1 This complex carbon framework holds ﬁve
contiguous stereogenic centers, two of them being adjacent
quaternary stereocenters. Despite the fact that no biological
activity has been reported to date for 1 and 2, the unique
architecture of these sesquiterpenes has constituted an
appealing challenge for the synthetic community and several
syntheses of echinopines have been accomplished to date.2−7
The key feature in all these syntheses is the establishment of the
unique [3,5,5,7] skeleton, and to this aim conceptually very
diﬀerent ring-forming sequences have been successfully
established.8 However, the assembly of the complex polycyclic
framework of the echinopines skeleton is not easily addressed
by conventional methods, as evidenced by the lengthy existing
syntheses, and it is in most of the cases delayed to one of the
last steps of the sequence.
Gold(I) catalysis constitutes a powerful tool for the
construction of complex polycyclic architectures from relatively
simple enyne substrates under mild reaction conditions.9−12 A
concise synthesis of the complex polycyclic framework of the
echinopines skeleton could easily provide access to structural
analogues for further evaluation of their biological properties. In
this context, we envisioned a gold(I)-catalyzed alkoxycycliza-
tion of cyclopropyl-tethered tricyclic 1,5- (3) or 1,6-enynes (4)
as the key step for the ready access to the tetracyclic skeleton of
echinopines via 5-endo or 5-exo cyclization, respectively
(Scheme 1).13−16 This transformation would stereoselectively
lead to echinopine-based tetracyclic products bearing diﬀerent
groups suited for further functionalization.
■ RESULTS AND DISCUSSION
Our approach for the synthesis of tricyclic enynes 3 and 4 relied
on a cobalt-catalyzed [6 + 2] cycloaddition between cyclo-
heptatriene and an internal alkyne as the key step to build the
bicyclo[4.2.1]nonane core.17,18 Thus, orthogonally protected
diol 5a aﬀorded cycloadduct 6a, which upon monodeprotection
and cyclopropanation of the tetrasubstituted oleﬁn from the
less sterically hindered face gave rise to tricyclic compound 8a
(Scheme 2). Oxidation of the primary alcohol and subsequent
homologation employing the Ohira−Bestmann reagent pro-
vided 1,5-enyne 3a.
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Initial attempts to perform the alkoxycyclization of 3a with
methanol as the external nucleophile in the presence of
diﬀerent cationic gold(I) complexes A−D only provided
methyl ketone 10 as a result of the formal hydration of the
terminal alkyne (Scheme 3).19−22 Moreover, when the reaction
was performed under strictly anhydrous conditions, the
corresponding dimethyl acetal 11 could be isolated, which
rapidly decomposed to 10 under ambient conditions, thus
demonstrating that the addition of methanol to the terminal
alkyne of 3a is favored over the attack of the alkene moiety.
Similar results were obtained when other alcohols were
employed as the external nucleophiles.
The use of carbonucleophiles such as indole, 1,3-diketones,
and electron-rich benzenes only resulted in the recovery of
unreacted 3a. Nevertheless, when the reaction of 3a was
performed with commercially available gold(I) complex A in
the presence of acetic acid, complete conversion of 3a was
achieved in 1 h, leading to the formation of rearranged product
12 in up to 61% yield (Scheme 4). A closer mechanistic
inspection of this transformation suggested that the gold(I)-
catalyzed reaction initially forms intermediate 14 that
rearranges to form allyl cation 15, which is trapped by acetic
acid. DFT calculations indicated that the formation of
intermediate 16 that leads to 12 is thermodynamically favored
over the formation of 17, which is predicted to be the driving
force for the rearrangement to take place. This result further
illustrates the inﬂuence of the cyclopropane functionality on the
reaction pathways followed in the gold(I)-catalyzed cyclizations
of cyclopropane-tethered 1,5-enynes23 and underscores the
propensity of the strained tetracyclic system of echinopines to
undergo rearrangements.6
In order to unequivocally ensure the structure of 12, the
acetate moiety was cleaved to form alcohol 18, which was
converted into the corresponding crystalline p-nitrobenzoate
derivative 19, whose structure was conﬁrmed by X-ray
diﬀraction (Scheme 5).24 In addition, a related system having
one of the double bonds reduced was also examined with the
aim of promoting a rearrangement toward the echinopine
skeleton on the basis of the higher stability of carbocation 24
over 22 predicted by DFT calculations. Thus, 18 could be
selectively hydrogenated in the presence of Crabtree’s catalyst
to give 20, which was converted into tertiary carbocation 22 via
triﬂate 21. Nonetheless, the rearranged product was not
observed and only nonrearranged elimination product 23 was
isolated under diﬀerent reaction conditions.
The synthesis of the homologous 1,6-enyne 4a commenced
with the cobalt-catalyzed [6 + 2] cycloaddition between
cycloheptatriene and alkyne 25 followed by treatment with
N-iodosuccinimide, which aﬀorded vinyl iodide 27 (Scheme 6).
Kumada cross-coupling of 27 with (3-(trimethylsilyl)prop-2-yn-
1-yl)magnesium bromide furnished 28, which was treated with
HF·py to give allylic alcohol 29. Cyclopropanation of the
tetrasubstituted oleﬁn followed by deprotection of the terminal
alkyne and protection of the primary alcohol gave rise to
tricyclic 1,6-enyne 4a. However, all attempts to perform the
alkoxycyclization of 4a in the presence of diﬀerent gold(I)
complexes provided only traces of the cyclized tetracyclic
product and resulted in the formation of methyl ketone 31 as
the major product.
Aldehydes 9a,b25 were next employed as the platform to
access a series of tricyclic 1,6-enynes featuring diﬀerent
functionalities at the propargylic position. Thus, the addition
of ethynylmagnesium bromide provided 4b,c as single
diastereoisomers and their alkoxycyclization was investigated
Scheme 3. Formal Hydration of 3a
Scheme 4. Gold-Catalyzed Rearrangement of 3aa
aValues in parentheses correspond to relative free energies in kcal
mol−1 (M06/6-31G(d) (C, H, P, O) and SDD (Au), solvent =
CH2Cl2). L = PMe3.
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using methanol as the external nucleophile in the presence of a
series of gold(I) complexes spanning a range of electro-
philicities. The desired alkoxycyclization products could only be
detected from the reactions carried out in the presence of
phosphine−gold(I) complexes, whereas gold(I) complexes
bearing NHC and phosphite ligands gave complex mixtures.26
Cationic gold(I) complex B provided the best results, and the
use of the alcohol as the solvent proved to be optimal for the
alkoxycyclization of enynes 4b,c to aﬀord regio- and stereo-
selectively tetracyclic products 32a−c, which feature the
[3,5,5,7] tetracyclic skeleton of echinopines (Scheme 7).
While the reaction of 4b with methanol provided 32a as a
single regioisomer, the analogous reaction of 4c gave rise to a
5:1 mixture of regioisomers. Nonetheless, changing the external
nucleophile from methanol to allyl alcohol in the reaction of 4c
resulted in the exclusive formation of 32c as the sole isomer.
The structure of tetracycles 32a−c could be conﬁrmed from
the X-ray crystal structure of 32a.24
Interestingly, the propargylic alcohol of enynes 4b,c was
substituted by a second molecule of alcohol in the gold(I)-
catalyzed cyclization process. In order to elucidate the order of
events in this transformation, the closely related system 34 in
which the 1,3-diene had been reduced to the corresponding
alkane was submitted to the optimized reaction conditions for
the gold(I)-catalyzed alkoxycyclization (Scheme 8). However,
after 2 h only hydroxyketone 35 and unreacted 34 were
detected from the crude mixture and no substitution of the
propargylic alcohol was observed.26 This result supports a
catalytic cycle in which the propargylic alcohol in 4b,c is
eliminated after the cyclization of the enyne by the attack of a
molecule of methanol to intermediate 36, which generates α,β-
unsaturated gold(I) carbene intermediate 37.27 The attack of a
second molecule of alcohol to 37 forms 38, which releases
tetracycles 32 by protodeauration (Scheme 9).
Ketoenynes 4d,e were also prepared by direct oxidation of
4b,c, and their alkoxycyclization under the optimized reaction
conditions provided mixtures of the two possible regioisomeric
products 39a′,b′ and 39a″,b″,28 which could be separated by
preparative chromatography (Scheme 10). Water could also be
used as the external nucleophile to aﬀord inseparable mixtures
of regioisomeric allylic alcohols 39c′,d′/39c″,d″ in moderate
yields.
■ CONCLUSION
In summary, the [3,5,5,7] tetracyclic core of echinopines can be
readily accessed through the gold(I)-catalyzed alkoxycyclization
of tricyclic cyclopropyl-tethered 1,6-enynes bearing an O
functionality at the propargylic position, giving access to
functionalized echinopine analogues as single stereoisomers.
Furthermore, the cyclization of 1,5-enyne 3a uncovered an
unexpected migration of the cyclopropane functionality, thus
providing access to the complex natural-product-like [3,6,5,7]
tetracycle 12.
■ EXPERIMENTAL SECTION
General Remarks. Chemicals and solvents for chromatography
were used as received. Solvents used in reactions under an inert
atmosphere were dried by passing through an activated alumina
column on a solvent puriﬁcation system. Analytical thin-layer
chromatography was carried out using TLC-aluminum sheets with
0.2 mm of silica gel (Merck FG254) with UV light as the visualizing
agent or an acidic solution of vanillin in ethanol as the developing
agent. Puriﬁcations by chromatography were carried out using ﬂash
grade silica gel (SDS Chromatogel 60 ACC, 40−60 mm). Preparative
TLC was performed on 20 cm × 20 cm silica gel plates. Organic
solutions were concentrated under reduced pressure on a rotary
evaporator. NMR spectra were recorded at 298 K on 300, 400, and
500 MHz devices. 1H and 13C chemical shifts (δ) are given in ppm
relative to TMS, and coupling constants (J) in Hz. Mass spectra were
recorded employing TOF mass analyzers (ESI, APCI). Melting points
were determined by observation of the fusion of the solids placed in a
capillary, through a magnifying glass. Crystal structure determinations
were carried out using a diﬀractometer equipped with an APPEX 2 4K
CCD area detector, an FR591 rotating anode with Mo Kα radiation,
Montel mirrors as the monochromator, and a Kryoﬂex low
temperature device (T = −173 °C). Full-sphere data collection was
used with ω and φ scans. Programs used: data collection APEX-2, data
reduction Bruker Saint V/.60A, and absorption correction SADABS.
Structure solution and reﬁnement: crustal structure solution was
achieved using direct methods as implemented in SHELXTL and
visualized using the program XP. Missing atoms were subsequently
located from diﬀerence Fourier synthesis and added to the atom list.
Least-squares reﬁnement on F2 using all measured intensities was
carried out using the program SHELXTL. All non-hydrogen atoms
were reﬁned including anisotropic displacement parameters.
tert-Butyl((4-methoxybut-2-yn-1-yl)oxy)dimethylsilane (5a).
NaH (60% in mineral oil, 1.89 g, 47.2 mmol) was added to a solution
of 4-((tert-butyldimethylsilyl)oxy)but-2-yn-1-ol29 (8.60 g, 42.9 mmol)
Scheme 5. Synthesis of 23 from Acetate 12 and CYLview
Depiction of the X-ray Crystal Structure of 19a
aValues in parentheses correspond to relative free energies in kcal
mol−1 (M06/6-31G(d), solvent = CH2Cl2).
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in anhydrous THF (210 mL) under argon at 0 °C. The resulting
suspension was stirred for 30 min, and then methyl iodide (3.2 mL,
51.5 mmol) was slowly added. The reaction mixture was warmed to
room temperature and then stirred for 1.5 h. After it was diluted with
Et2O (100 mL), the mixture was washed with a saturated solution of
NH4Cl (150 mL) and water (150 mL), the aqueous layers were
extracted with Et2O (2 × 100 mL), and the combined organic layers
were dried over MgSO4, ﬁltered, and concentrated under reduced
pressure. The product was obtained after puriﬁcation by ﬂash
Scheme 6. Synthesis and Formal Hydration of Tricyclic 1,6-Enyne 4a
Scheme 7. Synthesis and Alkoxycyclization of 4b,c and CYLview Depiction of the X-ray Crystal Structure of 32a
Scheme 8. Synthesis of 34 and Gold(I)-Catalyzed Reaction
under the Optimized Alkoxycyclization Reaction Conditions
Scheme 9. Catalytic Cycle for the Alkoxycyclization of 4b,c
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chromatography (cyclohexane/EtOAc 95/5) as a clear oil (8.00 g, 37.3
mmol, yield 87%). 1H NMR (400 MHz, CDCl3): δ 4.38 (t, J = 1.8 Hz,
2H), 4.15 (t, J = 1.8 Hz, 2H), 3.40 (s, 3H), 0.93 (s, 9H), 0.14 (s, 6H).
13C NMR (101 MHz, CDCl3): δ 85.1, 80.6, 60.0, 57.6, 51.7, 25.8, 18.3,
−5.2. HRMS (ESI+): m/z calcd for C11H22NaO2Si [M + Na]+,
237.1281; found, 237.1278.
Synthesis of 6. CoBr2 (306.1 mg, 1.40 mmol), Zn (366.1 mg, 5.60
mmol), and ZnI2 (1.79 g, 5.60 mmol) were suspended in anhydrous
1,2-dichloroethane (20 mL) under argon. Then P(OiPr)3 (0.69 mL,
2.80 mmol) was added, followed by cycloheptatriene (4.36 mL, 41.98
mmol) and a solution of 530 (27.99 mmol) in dry 1,2-dichloroethane
(8 mL). The resulting mixture was stirred at 50 °C for 16 h and then
ﬁltered through a pad of Celite and concentrated under reduced
pressure. Puriﬁcation of the resulting crude by ﬂash chromatography
(cyclohexane/EtOAc 1/0 to 95/5) aﬀorded compounds 6.
tert-Butyl(((1R*,6S*)-8-(methoxymethyl)bicyclo[4.2.1]nona-2,4,7-
trien-7-yl)methoxy)dimethylsilane (6a). Pale yellow oil (6.69 g, 21.83
mmol, yield 78%). 1H NMR (300 MHz, CDCl3): δ 6.29−6.11 (m,
2H), 5.84−5.74 (m, 2H), 4.35 (d, J = 13.1 Hz, 1H), 4.23 (d, J = 13.1
Hz, 1H), 4.12 (d, J = 12.3 Hz, 1H), 3.92 (d, J = 12.3 Hz, 1H), 3.41 (t, J
= 7.1 Hz, 1H), 3.32 (d, J = 7.1 Hz, 1H), 3.27 (s, 3H), 2.29−2.17 (m,
1H), 1.61 (d, J = 11.6 Hz, 1H), 0.93 (s, 9H), 0.08 (s, 3H), 0.07 (s,
3H). 13C NMR (75 MHz, CDCl3): δ 139.8, 139.8, 138.4, 132.1, 124.3,
124.2, 66.2, 57.8, 57.2, 45.4, 44.7, 30.0, 25.9, 18.4, −5.3, −5.4. HRMS
(ESI+): m/z calcd for C18H30NaO2Si [M + Na]
+, 329.1907; found,
329.1904.
(((1R*,6S*)-8-((Benzyloxy)methyl)bicyclo[4.2.1]nona-2,4,7-trien-
7-yl)methoxy) (tert-butyl)dimethylsilane (6b). Colorless oil (5.89 g,
15.39 mmol, yield 55%). 1H NMR (300 MHz, CDCl3): δ 7.40−7.29
(m, 5H), 6.26−6.14 (m, 2H), 5.84−5.74 (m, 2H), 4.48 (d, J = 11.8
Hz, 1H), 4.41 (d, J = 11.9 Hz, 1H), 4.32 (d, J = 13.0 Hz, 1H), 4.20 (d,
J = 12.6 Hz, 2H), 4.04 (d, J = 12.4 Hz, 1H), 3.43 (t, J = 7.1 Hz, 1H),
3.37 (t, J = 7.1 Hz, 1H), 2.25 (dt, J = 12.7, 6.7 Hz, 1H), 1.62 (d, J =
11.4 Hz, 1H), 0.92 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H). 13C NMR (126
MHz, CDCl3): δ 139.9, 139.8, 138.5, 138.5, 132.1, 128.3, 127.8, 127.5,
124.3, 124.3, 71.7, 63.7, 57.2, 45.5, 44.7, 30.0, 25.9, 18.4, −5.3, −5.4.
HRMS (ESI+): m/z calcd for C24H34NaO2Si [M + Na]
+, 405.2220;
found, 405.2230.
Synthesis of 7. TBAF (1.0 M in THF, 22.8 mL, 22.8 mmol) was
added to a solution of 6 (11.4 mmol) in anhydrous THF (200 mL) at
0 °C under argon. The mixture was stirred at room temperature for 2
h and then diluted with Et2O (100 mL) and washed with saturated
solution of NH4Cl (150 mL) and water (150 mL). The aqueous layers
were extracted with Et2O (2 × 100 mL), and the combined organic
layers were dried over MgSO4, ﬁltered, and concentrated under
reduced pressure. Puriﬁcation by ﬂash chromatography (cyclohexane/
EtOAc 7/3) aﬀorded products 7.
((1R*,6S*)-8-(Methoxymethyl)bicyclo[4.2.1]nona-2,4,7-trien-7-
yl)methanol (7a). Colorless oil (1.62 g, 8.4 mmol, yield 74%). 1H
NMR (400 MHz, CDCl3): δ 6.30−6.14 (m, 2H), 5.89−5.78 (m, 2H),
4.30 (dd, J = 13.2, 6.3 Hz, 1H), 4.24 (dd, J = 13.2, 4.9 Hz, 1H), 4.17
(d, J = 12.6 Hz, 1H), 4.00 (d, J = 12.4 Hz, 1H), 3.38−3.26 (m, 2H),
3.32 (s, 3H), 2.26 (dtt, J = 11.5, 6.8, 1.3 Hz, 1H), 1.95 (t, J = 5.7 Hz,
1H), 1.61 (d, J = 11.4 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ
139.3, 139.3, 137.6, 133.3, 124.6, 125,6, 66.6, 58.1, 57.6, 45.7, 45.7,
30.0. HRMS (ESI+): m/z calcd for C12H16NaO2 [M + Na]
+,
215.1043; found, 215.1042.
((1R*,6S*)-8-((Benzyloxy)methyl)bicyclo[4.2.1]nona-2,4,7-trien-7-
yl)methanol (7b). Colorless oil (2.29 g, 8.55 mmol, yield 75%). 1H
NMR (500 MHz, CDCl3): δ 7.41−7.30 (m, 5H), 6.28−6.16 (m, 2H),
5.86−5.84 (m, 1H), 5.84−5.81 (m, 1H), 4.52 (d, J = 11.8 Hz, 1H),
4.46 (d, J = 11.8 Hz, 1H), 4.31−4.19 (m, 3H), 4.11 (d, J = 12.5 Hz,
1H), 3.35 (t, J = 7.0 Hz, 2H), 2.27 (dtt, J = 11.5, 6.8, 1.2 Hz, 1H), 1.76
(s, 1H), 1.63 (d, J = 11.4 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ
139.4, 139.4, 138.1, 137.7, 133.5, 128.4, 127.8, 127.7, 124.6, 124.6,
72.2, 63.9, 57.5, 45.7, 45.7, 30.0. HRMS (ESI+): m/z calcd for
C18H20NaO2 [M + Na]
+, 291.1356; found, 291.1365.
Synthesis of 8. Diiodomethane (0.61 mL, 7.57 mmol) and ZnEt2
(1.0 M in hexanes, 15.75 mL, 15.75 mmol) were added to a solution of
7 (6.30 mmol) in anhydrous CH2Cl2 (210 mL) at 0 °C. The resulting
mixture was warmed to room temperature and stirred until TLC
analysis showed complete disappearance of the starting material (5−12
h). The reaction mixture was quenched by the slow addition of a
saturated aqueous Na/K-tartrate solution (100 mL), and after it was
stirred for 30 min the organic layer was separated, the aqueous layer
was extracted with CH2Cl2 (100 mL), and the combined organic
phases were dried over MgSO4 and concentrated under reduced
pressure. Puriﬁcation by ﬂash chromatography (cyclohexane/EtOAc
7/3) aﬀorded products 8.
((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-
2,4-dien-7-yl)methanol (8a). Colorless oil (1.22 g, 5.92 mmol, yield
94%). 1H NMR (500 MHz, CDCl3): δ 6.11−6.00 (m, 2H), 5.85−5.74
(m, 2H), 4.01 (dd, J = 10.0, 1.2 Hz, 1H), 3.84 (d, J = 11.7 Hz, 1H),
3.67 (d, J = 11.7 Hz, 1H), 3.38 (s, 3H), 3.10 (d, J = 10.0 Hz, 1H),
2.86−2.78 (m, 2H), 2.01 (dtt, J = 12.8, 6.3, 1.3 Hz, 1H), 1.78 (d, J =
13.1 Hz, 1H), 1.73 (d, J = 13.0 Hz, 1H), 0.81 (d, J = 5.6 Hz, 1H), 0.26
(d, J = 5.6 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 137.3, 136.5,
125.9, 125.0, 73.4, 64.2, 58.8, 42.1, 42.0, 41.4, 39.6, 26.6, 14.4. HRMS
Scheme 10. Synthesis and Alkoxycyclization of 4d,e
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.6b01607
J. Org. Chem. 2016, 81, 8444−8454
8448
(ESI+): m/z calcd for C13H18NaO2 [M + Na]
+, 229.1199; found,
229.1207.
((1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]deca-
2,4-dien-7-yl)methanol (8b). Colorless oil (1.53 g, 5.42 mmol, yield
86%). 1H NMR (500 MHz, CDCl3): δ 7.39−7.33 (m, 4H), 7.32−7.29
(m, 1H), 6.10−6.04 (m, 1H), 6.01−5.95 (m, 1H), 5.81−5.70 (m, 2H),
4.59 (d, J = 12.1 Hz, 1H), 4.52 (d, J = 12.1 Hz, 1H), 4.08 (dd, J = 10.0,
1.2 Hz, 1H), 3.82 (dd, J = 11.7, 7.0 Hz, 1H), 3.63 (d, J = 11.6 Hz, 1H),
3.21 (d, J = 10.0 Hz, 1H), 2.87 (t, J = 6.2 Hz, 1H), 2.81 (t, J = 6.2 Hz,
1H), 2.01 (dtt, J = 12.8, 6.3, 1.3 Hz, 1H), 1.79 (d, J = 13.0 Hz, 1H),
1.68 (s, 1H), 0.83 (d, J = 5.6 Hz, 1H), 0.26 (d, J = 5.6 Hz, 1H). 13C
NMR (126 MHz, CDCl3): δ 138.5, 137.3, 136.5, 128.4, 127.7, 127.6,
125.9, 125.0, 72.9, 70.9, 64.3, 42.1, 42.1, 41.5, 39.7, 26.6, 14.6. HRMS
(ESI+): m/z calcd for C19H22NaO2 [M + Na]
+, 305.1512; found,
305.1517.
Synthesis of 9. Dess−Martin periodinane (2.67 g, 6.30 mmol) was
added to a solution of 8 (4.85 mmol) in CH2Cl2 (50 mL). After the
addition of 1 drop of water the resulting suspension was stirred at
room temperature for 1 h and then washed with a 1/1 mixture of a
saturated solution of Na2S2O3/Na2CO3 (40 mL). The organic layer
was dried over MgSO4, ﬁltered, and concentrated under reduced
pressure. The product was obtained after puriﬁcation by ﬂash
chromatography (cyclohexane/EtOAc 7/3).
(1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-
diene-7-carbaldehyde (9a). Colorless oil (871.7 mg, 4.27 mmol, yield
88%). 1H NMR (500 MHz, CDCl3): δ 9.39 (s, 1H), 6.31 (ddq, J =
11.4, 7.5, 1.0 Hz, 1H), 5.99 (ddq, J = 12.3, 7.5, 1.0 Hz, 1H), 5.79 (ddd,
J = 11.4, 7.4, 0.9 Hz, 1H), 5.72 (ddd, J = 12.3, 7.4, 0.8 Hz, 1H), 3.95
(dd, J = 9.9, 1.4 Hz, 1H), 3.40 (s, 3H), 3.35 (d, J = 9.9 Hz, 1H), 3.00−
2.95 (m, 1H), 2.88 (t, J = 7.0 Hz, 1H), 2.05 (dtt, J = 12.9, 6.4, 1.3 Hz,
1H), 1.91 (d, J = 13.2 Hz, 1H), 1.25 (d, J = 5.8 Hz, 1H), 1.19 (dd, J =
5.8, 1.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 200.0, 136.6, 134.8,
125.7, 124.5, 71.5, 58.9, 51.8, 46.0, 41.3, 39.4, 26.5, 17.5. HRMS (ESI
+): m/z calcd for C13H16NaO2 [M + Na]
+, 227.1043; found, 227.1040.
(1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]deca-
2,4-diene-7-carbaldehyde (9b). Colorless oil (1.06 g, 3.78 mmol,
yield 78%). 1H NMR (500 MHz, CDCl3): δ 9.36 (s, 1H), 7.42−7.34
(m, 4H), 7.34−7.29 (m, 1H), 6.33−6.27 (m, 1H), 5.97−5.89 (m, 1H),
5.78−5.67 (m, 2H), 4.60 (d, J = 11.9 Hz, 1H), 4.52 (d, J = 11.9 Hz,
1H), 4.04 (dd, J = 9.9, 1.3 Hz, 1H), 3.48 (d, J = 9.8 Hz, 1H), 2.97 (dd,
J = 7.5, 6.3 Hz, 1H), 2.93 (t, J = 7.0 Hz, 1H), 2.06 (dtt, J = 12.9, 6.4,
1.3 Hz, 1H), 1.91 (d, J = 13.2 Hz, 1H), 1.26 (d, J = 5.8 Hz, 1H), 1.21
(dd, J = 5.9, 1.3 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 199.9,
138.2, 136.6, 134.8, 128.4, 127.7, 125.7, 124.4, 73.2, 69.2, 51.9, 46.1,
41.4, 39.4, 26.4, 17.7. HRMS (ESI+): m/z calcd for C19H20NaO2 [M +
Na]+, 303.1356; found, 303.1361.
(1R*,6S*,7S*,9S*)-7-Ethynyl-9-(methoxymethyl)tricyclo-
[4.3.1.07,9]deca-2,4-diene (3a). Ohira−Bestmann reagent (790 mg,
4.98 mmol) and K2CO3 (947.3 mg, 6.85 mmol) were sequentially
added to a solution of 9a (700 mg, 3.43 mmol) in MeOH (34 mL),
and the resulting mixture was stirred at room temperature for 16 h.
Then the volatiles were removed under reduced pressure and the
residue was dissolved in EtOAc (30 mL) and washed with water (30
mL) and brine (30 mL). The organic layer was dried over MgSO4,
ﬁltered, and concentrated under reduced pressure. Puriﬁcation by ﬂash
chromatography (cyclohexane/EtOAc 85/15) aﬀorded the product as
a colorless oil (391.6 mg, 1.96 mmol, yield 57%). 1H NMR (500 MHz,
CDCl3): δ 6.09−5.96 (m, 2H), 5.85−5.78 (m, 2H), 4.09 (dd, J = 10.2,
1.6 Hz, 1H), 3.40 (s, 3H), 3.10 (d, J = 10.2 Hz, 1H), 2.82 (dd, J = 6.7,
5.2 Hz, 1H), 2.80 (dd, J = 6.4, 5.3 Hz, 1H), 2.00−1.92 (m, 1H), 1.98
(s, 1H), 1.85 (dd, J = 13.2, 0.6 Hz, 1H), 0.98 (dd, J = 5.7, 1.6 Hz, 1H),
0.57 (d, J = 5.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 136.5,
135.6, 125.6, 125.0, 84.5, 74.2, 67.3, 58.8, 42.3, 40.6, 40.5, 30.0, 26.7,
17.2. HRMS (APCI+): m/z calcd for C14H17O [M + H]
+, 201.1274;
found, 201.1271.
1-((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]-
deca-2,4-dien-7-yl)ethan-1-one (10). To a solution of 3a (20.0
mg, 0.1 mmol) in MeOH (1 mL) was added gold(I) complex B31 (7.9
mg, 0.005 mmol), and the resulting mixture was stirred at room
temperature for 2 h. The reaction was quenched by the addition of 1
drop of Et3N, and the volatiles were removed under reduced pressure.
Puriﬁcation by column chromatography (cyclohexane/EtOAc 8/2)
aﬀorded the product as a colorless oil (21.6 mg, 0.099 mmol, yield
99%). 1H NMR (400 MHz, CDCl3): δ 6.12−6.02 (m, 2H), 5.82−5.70
(m, 2H), 3.96 (dd, J = 10.2, 1.4 Hz, 1H), 3.66 (d, J = 10.2 Hz, 1H),
3.40 (s, 3H), 3.03 (dd, J = 7.4, 6.5 Hz, 1H), 2.86 (dd, J = 7.4, 6.4 Hz,
1H), 2.29 (s, 3H), 2.05 (dddd, J = 13.0, 6.5, 5.1, 1.4 Hz, 1H), 1.82 (d, J
= 13.2 Hz, 1H), 1.11 (dd, J = 5.0, 1.4 Hz, 1H), 0.83 (d, J = 5.0 Hz,
1H). 13C NMR (101 MHz, CDCl3): δ 207.9, 136.5, 135.5, 124.9,
124.9, 72.1, 58.8, 49.4, 44.3, 41.3, 40.9, 31.5, 25.9, 20.8. HRMS (ESI+):
m/z calcd for C14H18NaO2 [M + Na]
+, 241.1199; found, 241.1193.
Isolation of the Acetal Intermediate (1R*,6S*,7R*,9S*)-7-(1,1-
Dimethoxyethyl)-9-(methoxymethyl)tricyclo[4.3.1.07,9]deca-2,4-
diene (11). Inside a glovebox, 3a (20 mg, 0.1 mmol) was dissolved in
anhydrous and degassed CH2Cl2 (1 mL) and then anhydrous MeOH
(41 μL, 1 mmol) and gold(I) complex B (7.9 mg, 0.005 mmol) were
sequentially added. The resulting mixture was stirred at room
temperature for 30 min and then quenched by the addition of 1
drop of Et3N. After removal of the volatiles under reduced pressure,
ﬁltration through a pad of basic Al2O3 aﬀorded the product as an
unstable colorless oil. 1H NMR (300 MHz, CDCl3): δ 6.10−5.99 (m,
2H), 5.80−5.64 (m, 2H), 3.89 (dd, J = 9.6, 1.4 Hz, 1H), 3.40 (s, 3H),
3.36 (d, J = 9.5 Hz, 1H), 3.20 (s, 3H), 3.04 (s, 3H), 2.83 (t, J = 6.7 Hz,
1H), 2.73 (dd, J = 7.7, 6.6 Hz, 1H), 2.06 (dt, J = 12.8, 6.4 Hz, 1H),
1.75 (d, J = 13.0 Hz, 1H), 1.40 (s, 3H), 0.80 (d, J = 5.1 Hz, 1H), 0.63
(dd, J = 5.1, 1.3 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 138.4,
136.5, 125.4, 124.4, 100.7, 72.5, 58.8, 48.8, 48.0, 42.3, 42.1, 29.7, 27.4,
23.2, 17.6, 12.1. HRMS could not be obtained due to decomposition
to 10.
(1R*,1aR*,3R*,5aR*)-1-(Methoxymethyl)-1,1a,2,2a,5a,7a-
hexahydro-3H-1,3-methanocyclopropa[f ]azulen-3-yl Acetate
(12). Gold(I) complex A (38.6 mg, 0.05 mmol) was added to a
solution of 3a (200.3 mg, 1 mmol) and AcOH (0.57 mL, 10 mmol) in
CH2Cl2 (10 mL), and the resulting mixture was stirred at room
temperature for 1 h. The reaction was quenched by the addition of 1
drop of Et3N, and the volatiles were removed under reduced pressure.
Puriﬁcation by column chromatography (cyclohexane/EtOAc 95/5 to
8/2) aﬀorded the product as a colorless oil (158.8 mg, 0.61 mmol, dr =
5:1, yield 61%). Data for the major isomer are as follows. 1H NMR
(400 MHz, CDCl3): δ 6.53 (dt, J = 6.0, 0.9 Hz, 1H), 5.74 (dd, J = 5.9,
3.1 Hz, 1H), 5.62 (ddd, J = 12.5, 7.9, 2.0 Hz, 1H), 5.28 (ddd, J = 12.4,
4.3, 1.4 Hz, 1H), 3.32 (s, 3H), 3.29 (d, J = 10.0 Hz, 1H), 3.12 (d, J =
10.0 Hz, 1H), 3.03−2.97 (m, 1H), 2.70 (dd, J = 16.8, 1.5 Hz, 1H),
2.48−2.42 (m, 1H), 2.33 (ddd, J = 14.5, 7.4, 5.1 Hz, 1H), 2.06 (s, 3H),
2.05 (d, J = 14.6 Hz, 1H), 1.65 (d, J = 11.2 Hz, 1H), 1.39−1.34 (m,
1H), 1.19 (t, J = 8.5 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 170.6,
137.6, 133.4, 126.8, 123.5, 85.9, 81.4, 58.1, 47.4, 42.8, 31.7, 28.1, 24.5,
22.1, 21.7, 19.1. HRMS (ESI+): m/z calcd for C16H20NaO3 [M +
Na]+, 283.1305; found, 283.1307.
(1R*,1aR*,3R*,5aR*)-1-(Methoxymethyl)-1,1a,2,2a,5a,7a-
hexahydro-3H-1,3-methanocyclopropa[f ]azulen-3-ol (18).
K2CO3 (253.9 mg, 1.92 mmol) was added to a solution of 12 (100
mg, 0.38 mmol) in a 1/1 mixture of CH2Cl2 and MeOH (4 mL), and
the resulting mixture was stirred at 50 °C for 16 h. After the mixture
was cooled to room temperature, the volatiles were removed under
reduced pressure and the resulting crude was puriﬁed by column
chromatography (cyclohexane/EtOAc 7/3 to 1/1) to give the product
as a colorless oil (69.7 mg, 0.32 mmol, dr > 20:1, yield 84%). 1H NMR
(400 MHz, CDCl3): δ 6.00 (dt, J = 5.8, 0.9 Hz, 1H), 5.68 (dd, J = 5.8,
3.2 Hz, 1H), 5.61 (ddd, J = 12.5, 7.9, 2.0 Hz, 1H), 5.29 (ddd, J = 12.4,
4.3, 1.4 Hz, 1H), 3.35 (s, 3H), 3.31 (d, J = 9.8 Hz, 1H), 3.15 (d, J = 9.8
Hz, 1H), 3.06−2.97 (m, 1H), 2.37 (ddd, J = 14.5, 7.4, 5.2 Hz, 1H),
2.19 (dd, J = 15.9, 1.5 Hz, 1H), 2.11 (t, J = 7.1 Hz, 1H), 2.02 (d, J =
14.6 Hz, 1H), 1.78 (s, 1H), 1.68 (d, J = 15.9 Hz, 1H), 1.36 (ddd, J =
9.0, 5.4, 1.3 Hz, 1H), 1.19 (t, J = 8.4 Hz, 1H). 13C NMR (101 MHz,
CDCl3): δ 141.4, 132.6, 127.1, 123.3, 81.8, 77.9, 58.4, 48.8, 45.7, 35.0,
28.3, 24.6, 21.7, 18.9. HRMS (ESI+): m/z calcd for C14H18NaO2 [M +
Na]+, 241.1199; found, 241.1205.
(1R*,1aR*,3R*,5aR*)-1-(Methoxymethyl)-1,1a,2,2a,5a,7a-
hexahydro-3H-1,3-methanocyclopropa[f ]azulen-3-yl 4-Nitro-
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benzoate (19). 4-Nitrobenzoyl chloride (30.6 mg, 0.16 mmol) was
added to a solution of 18 (30 mg, 0.14 mmol), Et3N (38 μL, 0.27
mmol), and DMAP (1.2 mg, 0.01 mmol) in anhydrous CH2Cl2 (3
mL), and the mixture was stirred at room temperature for 1 h and then
washed with H2O (2 × 5 mL). The organic layer was dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. Puriﬁca-
tion by column chromatography (cyclohexane/EtOAc 9/1) aﬀorded
the product as a white solid (51.3 mg, 0.14 mmol, yield quantitative).
Mp: 136−138 °C. 1H NMR (500 MHz, CDCl3): δ 8.32−8.29 (m,
2H), 8.24−8.20 (m, 2H), 6.63 (dt, J = 5.9, 0.9 Hz, 1H), 5.84 (dd, J =
5.9, 3.1 Hz, 1H), 5.68 (ddd, J = 12.5, 8.0, 2.1 Hz, 1H), 5.34 (ddd, J =
12.4, 4.2, 1.1 Hz, 1H), 3.32 (d, J = 10.0 Hz, 1H), 3.25 (s, 3H), 3.12−
3.09 (m, 1H), 3.11 (d, J = 10.0 Hz, 1H), 2.84 (dd, J = 16.9, 1.6 Hz,
1H), 2.73−2.68 (m, 1H), 2.43 (ddd, J = 14.7, 7.4, 5.2 Hz, 1H), 2.16
(d, J = 14.7 Hz, 1H), 1.80 (d, J = 16.8 Hz, 1H), 1.44 (dd, J = 8.9, 5.2
Hz, 1H), 1.29−1.23 (m, 1H). 13C NMR (126 MHz, CDCl3): δ 163.9,
150.4, 137.0, 136.9, 134.0, 130.6, 126.7, 123.7, 123.5, 88.0, 81.3, 58.2,
47.5, 42.7, 32.0, 28.1, 24.5, 21.7, 19.3. HRMS (ESI+): m/z calcd for
C21H21NNaO5 [M + Na]
+, 390.1312; found, 390.1315.
(1R*,1aR*,3S*,5aS*)-1-(Methoxymethyl)-1,1a,2,2a,4,5,5a,7a-
octahydro-3H-1,3-methanocyclopropa[f ]azulen-3-ol (20). A
round-bottom ﬂask containing a solution of 18 (50 mg, 0.23 mmol)
and Crabtree’s catalyst (3.7 mg, 0.0046 mmol) in anhydrous MeOH
(3 mL) was evacuated and back-ﬁlled with H2 (repeated three times).
The resulting mixture was stirred at room temperature for 1 h, then
the volatiles were removed under reduced pressure, and the crude
waqs puriﬁed by column chromatography (cyclohexane/EtOAc 1/1)
to aﬀord the product as a yellow oil (46.0 mg, 0.21 mmol, yield 91%).
1H NMR (400 MHz, CDCl3): δ 5.47−5.36 (m, 2H), 3.41−3.33 (m,
1H), 3.37 (s, 3H), 2.99 (d, J = 9.3 Hz, 1H), 2.54−2.46 (m, 1H), 2.29−
2.20 (m, 1H), 2.06−1.96 (m, 1H), 1.95−1.85 (m, 4H), 1.77−1.58 (m,
4H), 1.38−1.24 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 135.6,
120.0, 82.0, 74.6, 58.7, 43.5, 40.1, 38.6, 31.5, 29.3, 24.2, 22.4, 21.4,
18.4. HRMS (ESI+): m/z calcd for C14H20NaO2 [M + Na]
+,
243.1356; found, 243.1355.
(1R*,1aR*,5aS*)-1-(Methoxymethyl)-1a,2,2a,5,5a,7a-hexahy-
dro-1H-1,3-methanocyclopropa[f ]azulene (23). Tf2O (37 μL,
0.22 mmol) was slowly added to a solution of 20 (40 mg, 0.18 mmol),
pyridine (29 μL, 0.36 mmol), and DMAP (2.2 mg, 0.018 mmol) in
anhydrous CH2Cl2 (2 mL) at 0 °C. The reaction mixture was warmed
to room temperature and after stirring for 1 h was quenched by the
addition of H2O (2 mL). The organic layer was separated, dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. Puriﬁca-
tion by column chromatography (cyclohexane/EtOAc 98/2) aﬀorded
the product as a yellow oil (35.6 mg, 0.18 mmol, yield 98%). 1H NMR
(400 MHz, CDCl3): δ 5.51 (bs, 1H), 5.44 (ddd, J = 12.4, 7.3, 1.7 Hz,
1H), 5.40−5.34 (m, 1H), 3.63 (d, J = 9.9 Hz, 1H), 3.40 (s, 3H), 3.28
(d, J = 9.9 Hz, 1H), 2.55−2.49 (m, 1H), 2.27−2.11 (m, 5H), 2.05−
2.00 (m, 1H), 1.77−1.73 (m, 1H), 1.72−1.65 (m, 1H), 1.56 (t, J = 8.1,
7.6 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 147.9, 134.1, 121.3,
118.1, 79.6, 58.6, 44.1, 38.5, 36.7, 33.8, 30.8, 27.9, 27.8, 21.0. HRMS
(ESI+): m/z calcd for C14H18NaO [M + Na]
+, 225.1250; found,
225.1243.
tert-Butyldiphenyl(((1R*,6S*)-8-(trimethylsilyl)bicyclo[4.2.1]-
nona-2,4,7-trien-7-yl)methoxy)silane (26). CoBr2 (238.6 mg, 1.09
mmol), Zn (285.4 mg, 4.36 mmol), and ZnI2 (1.39 g, 4.36 mmol)
were suspended in anhydrous 1,2-dichloroethane (35 mL) under
argon. Then P(OiPr)3 (0.54 mL, 2.18 mmol) was added, followed by
cycloheptatriene (3.40 mL, 32.73 mmol) and a solution of 2532 (8.00
g, 21.82 mmol) in anhydrous 1,2-dichloroethane (9 mL). The
resulting mixture was stirred at 50 °C for 30 h and then ﬁltered
through a short pad of silica gel and concentrated under reduced
pressure. Puriﬁcation by ﬂash chromatography (cyclohexane/EtOAc
1/0 to 95/5) aﬀorded the product as a colorless oil (7.10 g, 15.49
mmol, yield 71%). 1H NMR (500 MHz, CDCl3): δ 7.74−7.68 (m,
4H), 7.48−7.39 (m, 6H), 6.16−6.10 (m, 1H), 6.09−6.03 (m, 1H),
5.83−5.72 (m, 2H), 4.43 (d, J = 12.8 Hz, 1H), 4.23 (d, J = 12.7 Hz,
1H), 3.69 (t, J = 7.2 Hz, 1H), 3.14 (t, J = 7.0 Hz, 1H), 2.14 (dtt, J =
11.4, 6.7, 1.2 Hz, 1H), 1.56 (d, J = 11.4 Hz, 1H), 1.11 (s, 9H), 0.01 (s,
9H). 13C NMR (75 MHz, CDCl3): δ 147.7, 139.2, 138.9, 135.7, 135.7,
135.6, 133.7, 133.7, 133.2, 129.6, 127.6, 127.6, 124.3, 123.5, 60.4, 48.5,
46.4, 30.8, 26.9, 19.3, 0.4. HRMS (ESI+): m/z calcd for C29H38NaOSi2
[M + Na]+, 481.2353; found, 481.2378.
tert-Butyl(((1R*,6S*)-8-iodobicyclo[4.2.1]nona-2,4,7-trien-7-
yl)methoxy)diphenylsilane (27). N-Iodosuccinimide (2.35 g, 10.45
mmol) was added to a solution of 26 (4.00 g, 8.72 mmol) in
anhydrous CH3CN (87 mL) under argon in darkness, and the
resulting mixture was stirred at room temperature for 16 h. The
reaction was quenched by the addition of a saturated solution of
Na2S2O3 (50 mL) and the product extracted with EtOAc (3 × 60 mL).
The combined organic layers were dried over MgSO4, ﬁltered, and
concentrated under reduced pressure. Puriﬁcation by ﬂash chromatog-
raphy (cyclohexane/EtOAc 95/5) aﬀorded the product as a pale
yellow oil (2.52 g, 4.88 mmol, yield 56%).33 1H NMR (500 MHz,
CDCl3): δ 7.73−7.66 (m, 4H), 7.48−7.38 (m, 6H), 6.20 (ddq, J =
11.2, 7.2, 1.1 Hz, 1H), 6.11 (ddq, J = 11.2, 7.3, 1.0 Hz, 1H), 5.95 (ddd,
J = 11.1, 7.5, 0.9 Hz, 1H), 5.86 (ddd, J = 11.0, 7.4, 0.9 Hz, 1H), 4.35
(d, J = 13.6, 0.8 Hz, 1H), 4.17 (d, J = 13.5 Hz, 1H), 3.50 (t, J = 7.0 Hz,
1H), 3.25 (t, J = 7.0 Hz, 1H), 2.31 (dtt, J = 11.3, 6.8, 1.2 Hz, 1H), 1.62
(d, J = 11.4 Hz, 1H), 1.10 (s, 9H). 13C NMR (101 MHz, CDCl3): δ
145.7, 139.1, 138.1, 135.6, 135.6, 133.4, 133.4, 129.7, 127.7, 125.4,
124.9, 84.5, 63.0, 52.9, 44.1, 30.8, 26.9, 19.3. HRMS (ESI+): m/z calcd
for C26H29INaOSi [M + Na]
+, 535.0925; found, 535.0919.
((1R*,6S*)-8-(3-(Trimethylsilyl)prop-2-yn-1-yl)bicyclo[4.2.1]-
nona-2,4,7-trien-7-yl)methanol (29). A dry two-neck round-
bottom ﬂask equipped with a condenser was charged with activated
magnesium tunings (583 mg, 24.0 mmol) that were covered with
anhydrous THF (100 mL). Dibromoethane (0.1 mL) was added,
followed by trimethylsilylpropargyl bromide (2.0 mL, 12.12 mmol).
The reaction mixture was heated at 50 °C for 1 h and then cooled to
room temperature and transferred via cannula to a second two-neck
round-bottom ﬂask containing a solution of 27 (1.23 g, 2.40 mmol)
and Pd(PPh3)4 (138.7 mg, 0.12 mmol) in anhydrous THF (30 mL).
The resulting mixture was stirred at 50 °C for 2 h and then cooled to
room temperature, poured on brine (100 mL), and extracted with
Et2O (2 × 100 mL). The combined organic layers were dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. Puriﬁca-
tion by ﬂash chromatography (cyclohexane/EtOAc 95/5) aﬀorded 28
as a yellow oil that was directly taken to the next step due to its low
stability. 1H NMR (400 MHz, CDCl3): δ 7.72−7.67 (m, 4H), 7.47−
7.36 (m, 6H), 6.27−6.18 (m, 1H), 6.17−6.09 (m, 1H), 5.83−5.71 (m,
2H), 4.33 (d, J = 12.8 Hz, 1H), 4.20 (d, J = 13.0 Hz, 1H), 3.42 (t, J =
7.0 Hz, 1H), 3.36 (t, J = 7.0 Hz, 1H), 2.95 (d, J = 19.4 Hz, 1H), 2.85
(d, J = 18.6 Hz, 1H), 2.26 (dtt, J = 11.3, 6.7, 1.2 Hz, 1H), 1.61 (d, J =
11.3 Hz, 1H), 1.08 (s, 9H), 0.16 (s, 9H). 13C NMR (101 MHz,
CDCl3): δ 140.2, 139.7, 135.6, 135.6, 135.0, 133.7, 133.6, 129.9, 129.6,
129.6, 127.7, 127.7, 124.4, 124.1, 104.8, 85.0, 58.5, 46.6, 45.0, 30.3,
26.8, 19.2, 17.2, 0.1. To a solution of 28 (646.0 mg, 1.30 mmol) in
THF (12 mL) in a Teﬂon ﬂask was added HF·py (70% weight, 0.31
mL, 12.1 mmol), and the resulting mixture was stirred at room
temperature for 16 h. The reaction was quenched by the slow addition
of a saturated solution of NaHCO3 (10 mL), and the product was
extracted with Et2O (2 × 10 mL). The combined organic layers were
dried over MgSO4, ﬁltered, and concentrated under reduced pressure.
Puriﬁcation by ﬂash chromatography (cyclohexane/EtOAc 8/2)
aﬀorded the product as a yellow oil (528.1 mg, 1.06 mmol, yield
over two steps 44%). 1H NMR (400 MHz, CDCl3): δ 6.31−6.19 (m,
2H), 5.87−5.78 (m, 2H), 4.29 (d, J = 12.7 Hz, 1H), 4.19 (d, J = 12.7
Hz, 1H), 3.37 (d, J = 7.2 Hz, 1H), 3.34 (d, J = 7.2 Hz, 1H), 3.17 (d, J
= 19.3 Hz, 1H), 3.11 (d, J = 19.1 Hz, 1H), 2.27 (dtt, J = 11.4, 6.7, 1.2
Hz, 1H), 1.61 (d, J = 11.4 Hz, 1H), 0.18 (s, 9H). 13C NMR (101
MHz, CDCl3): δ 139.8, 139.4, 135.1, 131.5, 124.7, 124.5, 104.4, 85.4,
57.3, 46.7, 45.4, 30.1, 17.2, 0.0. HRMS (ESI+): m/z calcd for
C16H22NaOSi [M + Na]
+, 281.1332; found, 281.1322.
((1R*,6S*,7R*,9S*)-9-(3-(Trimethylsilyl)prop-2-yn-1-yl)-
tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)methanol (30). To a sol-
ution of 29 (430 mg, 1.66 mmol) in anhydrous CH2Cl2 (83 mL) were
sequentially added CH2I2 (0.15 mL, 1.99 mmol) and ZnEt2 (1.0 M in
hexanes, 4.15 mL, 4.15 mmol), and the resulting solution was stirred at
room temperature for 3 h. The reaction mixture was quenched by the
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.6b01607
J. Org. Chem. 2016, 81, 8444−8454
8450
slow addition of a saturated aqueous Na/K-tartrate solution (100 mL),
and after the mixture was stirred for 30 min, the organic layer was
separated, the aqueous layer was extracted with CH2Cl2 (100 mL), and
the combined organic phases were dried over MgSO4 and
concentrated under reduced pressure. Puriﬁcation by ﬂash chromatog-
raphy (cyclohexane/EtOAc 8/2) aﬀorded the product as a pale yellow
oil (378.0 mg, 1.39 mmol, yield 84%). 1H NMR (400 MHz, CDCl3): δ
6.11−6.00 (m, 2H), 5.84−5.70 (m, 2H), 3.92 (d, J = 11.6 Hz, 1H),
3.57 (d, J = 11.5 Hz, 1H), 2.89 (dd, J = 17.3, 0.8 Hz, 1H), 2.85−2.75
(m, 2H), 2.07 (d, J = 17.3 Hz, 1H), 1.99 (ddd, J = 12.8, 7.0, 5.7 Hz,
1H), 1.74 (d, J = 13.1 Hz, 1H), 1.50 (s, 1H), 0.74 (d, J = 5.7 Hz, 1H),
0.18 (s, 10H). 13C NMR (101 MHz, CDCl3): δ 136.9, 136.5, 125.7,
125.3, 105.4, 85.8, 64.0, 43.1, 42.3, 41.4, 38.9, 26.2, 21.0, 14.3, 0.1.
HRMS (ESI+): m/z calcd for C17H24NaOSi [M + Na]
+, 295.1489;
found, 295.1482.
tert-Butyldimethyl(((1R*,6S*,7R*,9R*)-9-(prop-2-yn-1-yl)-
tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)methoxy)silane (4a).
TBAF (1.0 M solution in THF, 1.53 mL, 1.53 mmol) was added to
a solution of 30 (378.1 mg, 1.39 mmol) in THF (14 mL) at 0 °C, and
the resulting solution was warmed to room temperature and stirred for
15 min. Then the mixture was poured on brine (30 mL) and the
product was extracted with Et2O (2 × 20 mL). The combined organic
layers were dried over MgSO4, ﬁltered, and concentrated under
reduced pressure. Puriﬁcation by ﬂash chromatography (cyclohexane/
EtOAc 8/2) aﬀorded ((1R*,6S*,7R*,9R*)-9-(prop-2-yn-1-yl)tricyclo-
[4.3.1.07,9]deca-2,4-dien-7-yl)methanol (30′) as a colorless oil (222.7
mg, 1.11 mmol, yield 80%). 1H NMR (400 MHz, CDCl3): δ 6.12−
6.03 (m, 2H), 5.84−5.76 (m, 2H), 3.91 (d, J = 11.6 Hz, 1H), 3.60 (d, J
= 11.6 Hz, 1H), 2.91 (ddd, J = 17.1, 2.7, 0.9 Hz, 1H), 2.84 (td, J = 6.8,
4.0 Hz, 2H), 2.04 (t, J = 2.7 Hz, 1H), 2.03−1.95 (m, 2H), 1.75 (d, J =
13.1 Hz, 1H), 1.53 (s, 1H), 0.76 (d, J = 5.7 Hz, 1H), 0.17 (d, J = 5.7
Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 136.9, 136.4, 125.8, 125.3,
82.8, 69.1, 64.1, 42.8, 42.3, 41.6, 38.8, 26.1, 19.7, 14.3. HRMS (APCI
+): m/z calcd for C14H17O [M + H]
+, 201.1274; found, 201.1266.
TBSCl (165.6 mg, 1.10 mmol) and imidazole (136.2 mg, 2.00 mmol)
were added to a solution of 30′ (200.3 mg, 1.00 mmol) in CH2Cl2 (10
mL), and the mixture was stirred at room temperature for 1 h. Then it
was washed with H2O (10 mL) and brine (10 mL) and the organic
layer was dried over MgSO4, ﬁltered, and concentrated under reduced
pressure. Puriﬁcation by column chromatography (cyclohexane)
aﬀorded the product as a colorless oil (314.4 mg, 0.99 mmol, yield
99%). 1H NMR (400 MHz, CDCl3): δ 6.06−5.92 (m, 2H), 5.79−5.69
(m, 2H), 4.08 (dd, J = 10.4, 1.1 Hz, 1H), 3.37 (d, J = 10.4 Hz, 1H),
2.85−2.73 (m, 3H), 2.04−1.94 (m, 3H), 1.72 (d, J = 13.0 Hz, 1H),
0.91 (s, 9H), 0.71 (d, J = 5.6 Hz, 1H), 0.22 (d, J = 5.7 Hz, 1H), 0.06
(s, 3H), 0.04 (s, 3H). 13C NMR (101 MHz, CDCl3): δ 136.8, 136.4,
125.3, 124.9, 83.2, 68.8, 63.0, 43.1, 42.4, 41.5, 38.3, 26.0, 25.9, 19.1,
18.3, 13.6, −5.2, −5.4. HRMS (ESI+): m/z calcd for C20H30NaOSi [M
+ Na]+, 337.1958; found, 337.1945.
1-((1R*,6S*,7R*,9S*)-9-(((tert-Butyldimethylsilyl)oxy)-
methyl)tricyclo[4.3.1.07,9]deca-2,4-dien-7-yl)propan-2-one
(31). Gold(I) complex (0.002 mmol) was added to a solution of 4a
(0.1 mmol) in MeOH (1 mL), and the resulting mixture was stirred at
room temperature for 2 h before the addition of 1 drop of Et3N. Then
the volatiles were removed under reduced pressure, and puriﬁcation by
column chromatography aﬀorded the product in 22−47% yield. 1H
NMR (400 MHz, CDCl3): δ 5.98−5.83 (m, 2H), 5.77−5.69 (m, 2H),
4.09 (d, J = 10.6 Hz, 1H), 3.37 (d, J = 10.4 Hz, 1H), 3.01 (d, J = 16.1
Hz, 1H), 2.76 (t, J = 7.2 Hz, 1H), 2.73 (t, J = 6.7 Hz, 1H), 2.18 (s,
3H), 2.14 (d, J = 16.0 Hz, 1H), 2.04−1.95 (m, 1H), 1.71 (d, J = 13.0
Hz, 1H), 0.91 (s, 9H), 0.79 (d, J = 5.7 Hz, 1H), 0.21 (d, J = 5.7 Hz,
1H), 0.06 (s, 3H), 0.06 (s, 3H). 13C NMR (101 MHz, CDCl3): δ
208.9, 136.6, 136.5, 125.2, 125.1, 63.1, 43.7, 42.9, 41.8, 41.0, 35.6, 30.2,
26.4, 25.9, 18.3, 13.9, −5.2, −5.4. HRMS (ESI+): m/z calcd for
C20H32NaO2Si [M + Na]
+, 355.2064; found, 355.2056.
Synthesis of 4b,c. Ethynylmagnesium bromide (0.5 M in THF,
8.07 mL, 4.04 mmol) was added to a solution of 9 (3.67 mmol) in
anhydrous THF (37 mL) at 0 °C. After it was stirred at room
temperature for 30 min, the reaction mixture was diluted with Et2O
(15 mL) and quenched by the addition of saturated NH4Cl aqueous
solution (50 mL). The aqueous layer was extracted with Et2O (2 × 40
mL), the combined organic phases were dried over MgSO4, ﬁltered,
and concentrated under reduced pressure, and the resulting crude was
puriﬁed by column chromatography (cyclohexane/EtOAc 7/3).
1-((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-
2,4-dien-7-yl)prop-2-yn-1-ol (4b). Pale yellow solid (769.2 mg, 3.34
mmol, yield 91%). Mp: 82−84 °C. 1H NMR (400 MHz, CDCl3): δ
6.10−5.99 (m, 2H), 5.84−5.72 (m, 2H), 4.94 (s, 1H), 3.87 (dd, J =
10.1, 0.7 Hz, 1H), 3.68 (d, J = 10.1 Hz, 1H), 3.37 (s, 3H), 2.97 (s,
1H), 2.82 (dd, J = 7.1, 6.2 Hz, 1H), 2.76 (dd, J = 7.1, 6.2 Hz, 1H), 2.54
(d, J = 2.2 Hz, 1H), 2.12−2.03 (m, 1H), 1.76 (d, J = 13.0 Hz, 1H),
0.76 (d, J = 5.9 Hz, 1H), 0.74 (d, J = 6.1 Hz, 1H). 13C NMR (101
MHz, CDCl3): δ 137.2, 136.0, 126.2, 125.0, 84.0, 73.5, 72.0, 61.1, 58.7,
43.8, 43.3, 43.0, 40.2, 26.3, 10.6. HRMS (APCI+): m/z calcd for
C15H18NaO2 [M + Na]
+, 253.1199; found, 253.1211.
1-((1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]-
deca-2,4-dien-7-yl)prop-2-yn-1-ol (4c). Colorless oil (923.0 mg, 3.01
mmol, yield 82%). 1H NMR (500 MHz, CDCl3): δ 7.39−7.33 (m,
4H), 7.33−7.29 (m, 1H), 6.06 (dd, J = 10.7, 7.5 Hz, 1H), 6.00 (dd, J =
9.7, 7.5 Hz, 1H), 5.80 (ddd, J = 11.3, 7.4, 0.9 Hz, 1H), 5.74 (ddd, J =
11.2, 7.4, 0.9 Hz, 1H), 4.95 (dd, J = 4.0, 2.2 Hz, 1H), 4.60 (d, J = 11.9
Hz, 1H), 4.51 (d, J = 11.9 Hz, 1H), 3.97 (d, J = 10.2 Hz, 1H), 3.80 (d,
J = 10.2 Hz, 1H), 2.89 (d, J = 4.1 Hz, 1H), 2.85−2.79 (m, 2H), 2.51
(d, J = 2.2 Hz, 1H), 2.08 (dtt, J = 12.8, 6.3, 1.3 Hz, 1H), 1.77 (d, J =
13.1 Hz, 1H), 0.79−0.75 (m, 2H). 13C NMR (126 MHz, CDCl3): δ
138.1, 137.3, 136.0, 128.4, 127.7, 127.6, 126.3, 125.0, 83.9, 73.6, 73.0,
69.7, 61.2, 43.8, 43.3, 43.0, 40.3, 26.4, 11.0. HRMS (ESI+): m/z calcd
for C21H22NaO2 [M + Na]
+, 329.1512; found, 329.1518.
Gold-Catalyzed Cyclization of 1,6-Enynes 4b,c. Gold(I)
complex B (3.1 mg, 0.002 mmol) was added to a solution of 4b,c
(0.1 mmol) in ROH (1 mL), and the resulting suspension was stirred
at room temperature for 2 h before the addition of 1 drop of Et3N.
Then the volatiles were removed under reduced pressure and the
resulting crude was puriﬁed by column chromatography to aﬀord
tetracycles 32.
(1aR*,2S*,3aS*,4S*,6R*,6aS*,7R*)-6,7-Dimethoxy-1a-(methoxy-
methyl)-5-methylene-1,1a,2,3,3a,4,5,6-octahydro-2,4-prop[1]-
enocyclopropa[c]pentalene (32a). Puriﬁcation: pentane/CH2Cl2 9/
1. White solid (25.1 mg, yield 91%). 32a:32a′ > 20:1. Mp: 95−97 °C.
1H NMR (500 MHz, CDCl3): δ 6.12 (ddd, J = 11.6, 6.8, 1.5 Hz, 1H),
5.76 (ddd, J = 11.6, 7.3, 0.6 Hz, 1H), 5.17 (d, J = 2.9 Hz, 1H), 5.04 (d,
J = 2.4 Hz, 1H), 3.98 (dd, J = 7.3, 3.7 Hz, 1H), 3.70 (dd, J = 9.8, 1.6
Hz, 1H), 3.47 (s, 1H), 3.41 (s, 3H), 3.36 (s, 3H), 3.36−3.29 (m, 1H),
3.33 (s, 3H), 2.90 (dd, J = 9.7, 6.6 Hz, 1H), 2.84−2.80 (m, 2H), 2.50
(d, J = 13.7 Hz, 1H), 1.42 (dtd, J = 13.6, 6.7, 1.6 Hz, 1H), 1.12 (dd, J =
5.8, 1.6 Hz, 1H), 1.08 (d, J = 5.8 Hz, 1H). 13C NMR (101 MHz,
CDCl3): δ 151.2, 140.2, 127.6, 110.9, 85.7, 80.8, 74.1, 58.7, 56.6, 55.6,
45.9, 45.6, 42.8, 40.9, 36.1, 30.3, 16.0. HRMS (ESI+): m/z calcd for
C17H24NaO3 [M + Na]
+, 299.1618; found, 299.1626. Note: this
reaction could be scaled up to obtain 400 mg of 32a without any
decrease in yield or selectivity. X-ray-quality single crystals were
obtained by slow evaporation of a solution of 32a in CH2Cl2 at 5 °C.
(1aR*,2S*,3aS*,4S*,6R*,6aS*,7R*)-1a-((Benzyloxy)methyl)-6,7-
dimethoxy-5-methylene-1,1a,2,3,3a,4,5,6-octahydro-2,4-prop[1]-
enocyclopropa[c]pentalene (32b). Puriﬁcation: cyclohexane/EtOAc
1/0 to 95/5. Colorless oil (29.6 mg, yield 84%). 32b:32b′ = 5:1. Data
for the major isomer are as follows. 1H NMR (500 MHz, CDCl3): δ
7.40−7.34 (m, 4H), 7.33−7.29 (m, 1H), 6.09 (ddd, J = 11.6, 6.7, 1.5
Hz, 1H), 5.72 (ddd, J = 11.6, 7.3, 0.6 Hz, 1H), 5.15 (d, J = 2.9 Hz,
1H), 5.03 (d, J = 2.4 Hz, 1H), 4.57 (d, J = 12.1 Hz, 1H), 4.52 (d, J =
12.1 Hz, 1H), 3.97 (dd, J = 7.3, 3.7 Hz, 1H), 3.78 (dd, J = 9.8, 1.5 Hz,
1H), 3.45 (d, J = 1.2 Hz, 1H), 3.41 (s, 3H), 3.32 (s, 1H), 3.32 (s, 3H),
2.96 (d, J = 9.8 Hz, 1H), 2.91 (dd, J = 10.0, 6.3 Hz, 1H), 2.87 (t, J =
6.9 Hz, 1H), 2.51 (d, J = 13.7 Hz, 1H), 1.47−1.40 (m, 1H), 1.14 (dd, J
= 5.8, 1.5 Hz, 1H), 1.10 (d, J = 5.8 Hz, 1H). 13C NMR (126 MHz,
CDCl3): δ 151.2, 140.2, 138.5, 128.4, 128.4, 127.6, 127.6, 110.9, 85.7,
80.8, 72.7, 71.5, 56.6, 55.6, 46.0, 45.7, 42.9, 41.0, 36.3, 30.3, 16.1.
HRMS (ESI+): m/z calcd for C23H28NaO3 [M + Na]
+, 375.1931;
found, 375.1925.
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(1aR* ,2S* ,3aS* ,4S* ,6R* ,6aS* ,7R*)-6,7-Bis(allyloxy)-1a-
((benzyloxy)methyl)-5-methylene-1,1a,2,3,3a,4,5,6-octahydro-2,4-
prop[1]enocyclopropa[c]pentalene (32c). Puriﬁcation: cyclohexane/
EtOAc 1/0 to 95/5. White solid (30.0 mg, yield 84%). 32c:32c′ >
20:1. Mp: 138−140 °C. 1H NMR (500 MHz, CDCl3): δ 7.39−7.34
(m, 4H), 7.33−7.29 (m, 1H), 6.07 (ddd, J = 11.6, 6.8, 1.5 Hz, 1H),
6.01−5.88 (m, 2H), 5.69 (ddd, J = 11.6, 7.3, 0.6 Hz, 1H), 5.31 (dq, J =
17.2, 1.7 Hz, 1H), 5.26 (dq, J = 17.2, 1.7 Hz, 1H), 5.20 (dq, J = 10.4,
1.8 Hz, 1H), 5.17 (dq, J = 10.2, 1.9 Hz, 1H), 5.13 (d, J = 2.9 Hz, 1H),
4.99 (d, J = 2.4 Hz, 1H), 4.56 (d, J = 12.1 Hz, 1H), 4.51 (d, J = 12.1
Hz, 1H), 4.13 (dd, J = 7.4, 3.8 Hz, 1H), 4.09 (dt, J = 5.5, 1.5 Hz, 1H),
4.08 (dt, J = 5.7, 1.5 Hz, 1H), 4.05 (dq, J = 5.7, 1.6 Hz, 1H), 3.97 (ddt,
J = 12.7, 6.0, 1.4 Hz, 1H), 3.77 (dd, J = 9.8, 1.5 Hz, 1H), 3.65 (s, 1H),
3.34 (dq, J = 9.5, 3.0 Hz, 1H), 2.96 (d, J = 6.3 Hz, 1H), 2.94 (d, J = 6.4
Hz, 1H), 2.87 (t, J = 6.7 Hz, 1H), 2.57 (d, J = 13.7 Hz, 1H), 1.48−1.42
(m, 1H), 1.16 (dd, J = 5.8, 1.5 Hz, 1H), 1.09 (d, J = 5.8 Hz, 1H). 13C
NMR (126 MHz, CDCl3): δ 151.8, 140.1, 138.5, 135.4, 135.3, 128.4,
127.8, 127.6, 127.6, 116.9, 116.8, 110.8, 83.2, 78.2, 72.7, 71.5, 69.7,
68.5, 46.3, 45.7, 42.9, 41.1, 36.3, 30.3, 16.3. HRMS (ESI+): m/z calcd
for C27H32NaO3 [M + Na]
+, 427.2244; found, 427.2227.
((1R*,6S*,7S*,9R*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]-
decan-7-yl)methanol (33). A round-bottom ﬂask containing a
solution of 8a (200 mg, 0.97 mmol) and Pd(OH)2/C (20 wt %, 28.1
mg, 0.048 mmol) in anhydrous MeOH (10 mL) was evacuated and
back-ﬁlled with H2 (repeated three times). The resulting mixture was
stirred at room temperature for 4 h, and then the volatiles were
removed under reduced pressure and the crude was puriﬁed by
column chromatography (cyclohexane/EtOAc 1/1) to aﬀord the
product as a colorless oil (204.0 mg, 0.97 mmol, yield quantitative). 1H
NMR (400 MHz, CDCl3): δ 4.02 (dd, J = 11.6, 1.1 Hz, 1H), 3.79 (dd,
J = 10.2, 1.0 Hz, 1H), 3.48 (d, J = 11.6 Hz, 1H), 3.37 (s, 3H), 3.27 (d,
J = 10.1 Hz, 1H), 2.43−1.36 (m, 2H), 2.01−1.93 (m, 1H), 1.91−1.82
(m, 1H), 1.70−1.34 (m, 9H), 0.88 (dt, J = 4.7, 1.1 Hz, 1H), 0.52 (d, J
= 4.6 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 73.6, 63.4, 58.8, 40.4,
39.8, 36.3, 34.7, 29.1, 29.1, 28.9, 25.1, 24.8, 18.4. HRMS (ESI+): m/z
calcd for C13H22NaO2 [M + Na]
+, 233.1512; found, 233.1511.
(R*)-1-((1R*,6S*,7S*,9R*)-9-(Methoxymethyl)tricyclo-
[4.3.1.07,9]decan-7-yl)prop-2-yn-1-ol (34). Dess−Martin period-
inane (524.3 mg, 1.24 mmol) was added to a solution of 33 (200 mg,
0.95 mmol) in CH2Cl2 (10 mL). After the addition of 1 drop of water
the resulting suspension was stirred at room temperature for 15 min
and then washed with a 1/1 mixture of saturated solution of Na2S2O3/
Na2CO3 (20 mL). The organic layer was dried over MgSO4, ﬁltered,
and concentrated under reduced pressure. The product (33′) was
obtained after ﬁltration through a pad of silica gel as a colorless oil and
directly submitted to the next step. 1H NMR (500 MHz, CDCl3): δ
9.44 (s, 1H), 3.86 (dd, J = 10.2, 1.3 Hz, 1H), 3.54 (d, J = 10.2 Hz, 1H),
3.39 (s, 3H), 2.66 (ddd, J = 7.3, 4.4, 2.7 Hz, 1H), 2.51−2.41 (m, 2H),
1.97−1.88 (m, 1H), 1.64−1.40 (m, 9H), 1.37 (dd, J = 4.9, 1.3 Hz,
1H). 13C NMR (126 MHz, CDCl3): δ 200.7, 71.6, 58.9, 45.5, 43.1,
39.5, 38.1, 30.2, 29.6, 27.8, 25.5, 24.3, 23.4. Ethynylmagnesium
bromide (0.5 M in THF, 2.01 mL, 1.00 mmol) was added to a solution
of aldehyde 33′ (190 mg, 0.91 mmol) in anhydrous THF (9 mL) at 0
°C. After it was stirred at room temperature for 30 min, the reaction
mixture was diluted with Et2O (15 mL) and quenched by the addition
of saturated NH4Cl aqueous solution (50 mL). The aqueous layer was
extracted with Et2O (2 × 40 mL), the combined organic phases were
dried over MgSO4, ﬁltered, and concentrated under reduced pressure,
and the resulting crude was puriﬁed by column chromatography
(cyclohexane/EtOAc 7/3) to aﬀord 34 as a colorless oil (208.9 mg,
0.89 mmol, yield over two steps 98%). 1H NMR (500 MHz, CDCl3):
δ 4.87 (dd, J = 5.2, 2.2 Hz, 1H), 3.81 (d, J = 10.4 Hz, 1H), 3.70 (d, J =
10.3 Hz, 1H), 3.48 (d, J = 5.3 Hz, 1H), 3.36 (s, 3H), 2.51 (d, J = 2.2
Hz, 1H), 2.42 (ddd, J = 7.7, 5.3, 2.4 Hz, 1H), 2.31 (ddd, J = 7.8, 6.1,
1.9 Hz, 1H), 2.08−2.01 (m, 1H), 1.86−1.79 (m, 1H), 1.78−1.71 (m,
1H), 1.70−1.61 (m, 1H), 1.57−1.42 (m, 4H), 1.40−1.32 (m, 2H),
0.94 (d, J = 4.7 Hz, 1H), 0.82 (d, J = 4.7 Hz, 1H). 13C NMR (126
MHz, CDCl3): δ 84.5, 74.0, 72.8, 61.1, 58.4, 42.1, 41.5, 38.7, 35.8,
29.6, 29.1, 29.0, 25.2, 24.5, 16.4. HRMS (ESI+): m/z calcd for
C15H22NaO2 [M + Na]
+, 257.1512; found, 257.1514.
Synthesis of 4d,e. Dess-Martin periodinane (478.8 mg, 1.13
mmol) was added to a solution of 4b,c (0.87 mmol) in CH2Cl2 (9
mL). After the addition of 1 drop of water, the resulting suspension
was stirred at room temperature for 1 h and then washed with a 1/1
mixture of a saturated solution of Na2S2O3/Na2CO3 (40 mL). The
organic layer was dried over MgSO4, ﬁltered, and concentrated under
reduced pressure. The product was obtained after puriﬁcation by ﬂash
chromatography (cyclohexane/EtOAc 7/3).
1-((1R*,6S*,7R*,9S*)-9-(Methoxymethyl)tricyclo[4.3.1.07,9]deca-
2,4-dien-7-yl)prop-2-yn-1-one (4d). Yellow oil (121.2 mg, 0.53 mmol,
yield 61%). 1H NMR (400 MHz, CDCl3): δ 6.32 (ddd, J = 11.4, 7.4,
1.1 Hz, 1H), 6.02 (ddd, J = 11.2, 7.7, 0.9 Hz, 1H), 5.79 (ddd, J = 11.5,
7.4, 0.8 Hz, 1H), 5.70 (ddd, J = 11.4, 7.4, 0.8 Hz, 1H), 4.02 (dd, J =
10.1, 1.5 Hz, 1H), 3.82 (d, J = 10.1 Hz, 1H), 3.42 (s, 3H), 3.26 (s,
1H), 3.12−3.06 (m, 1H), 2.91 (t, J = 7.0 Hz, 1H), 2.06−1.98 (m, 1H),
1.85 (dd, J = 13.2, 0.6 Hz, 1H), 1.34 (dd, J = 5.5, 1.4 Hz, 1H), 1.26 (d,
J = 5.5 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 185.7, 136.9, 134.8,
125.5, 124.1, 82.0, 79.1, 71.4, 58.8, 52.3, 45.5, 41.7, 40.4, 25.6, 22.5.
HRMS (ESI+): m/z calcd for C15H16NaO2 [M + Na]
+, 251.1043;
found, 251.1035.
1-((1R*,6S*,7R*,9S*)-9-((Benzyloxy)methyl)tricyclo[4.3.1.07,9]-
deca-2,4-dien-7-yl)prop-2-yn-1-one (4e). Yellow oil (174.9 mg, 0.57
mmol, yield 66%). 1H NMR (500 MHz, CDCl3): δ 7.42−7.34 (m,
4H), 7.34−7.29 (m, 1H), 6.32 (ddq, J = 11.3, 7.6, 0.7 Hz, 1H), 5.97
(ddq, J = 11.4, 7.5, 1.0 Hz, 1H), 5.75 (ddd, J = 11.3, 7.4, 0.8 Hz, 1H),
5.67 (ddd, J = 11.4, 7.3, 0.8 Hz, 1H), 4.61 (d, J = 11.9 Hz, 1H), 4.58
(d, J = 12.0 Hz, 1H), 4.10 (dd, J = 10.1, 1.5 Hz, 1H), 3.95 (d, J = 10.0
Hz, 1H), 3.11 (s, 1H), 3.07 (t, J = 7.1 Hz, 1H), 2.98 (t, J = 7.0 Hz,
1H), 2.02 (dtt, J = 13.0, 6.4, 1.3 Hz, 1H), 1.85 (d, J = 14.0 Hz, 1H),
1.35 (dd, J = 5.6, 1.4 Hz, 1H), 1.27 (d, J = 5.6 Hz, 1H). 13C NMR
(126 MHz, CDCl3): δ 185.7, 138.5, 137.0, 134.7, 128.4, 127.8, 127.6,
125.5, 124.0, 81.7, 79.2, 73.0, 68.9, 52.6, 45.7, 41.8, 40.4, 25.5, 22.5.
HRMS (ESI+): m/z calcd for C21H20NaO2 [M + Na]
+, 327.1356;
found, 327.1363.
Gold-Catalyzed Cyclizations of 1,6-Enynes 4d,e. Gold(I)
complex B (3.1 mg, 0.002 mmol)31 was added to a solution of 4d,e
(0.1 mmol) in ROH (1 mL) or a 2/1 dioxane/H2O mixture (2 mL),
and the resulting suspension was stirred at room temperature for the
appointed time before the addition of 1 drop of Et3N. Then the
volatiles were removed under reduced pressure and puriﬁcation by
preparative TLC aﬀorded the tetracyclic products 39′/39″.
(1aR*,2S*,3aS*,4S*,6aS*,7R*)-1a-((Benzyloxy)methyl)-7-me-
thoxy-5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]-
enocyclopropa[c]pentalen-6(1H)-one (39a′). General procedure
starting from 4e and methanol. Reaction time: 1 h. Puriﬁcation:
cyclohexane/EtOAc 95/5 (eluted three times). White solid (15.1 mg,
yield 45%). Mp: 59−61 °C. 1H NMR (400 MHz, CDCl3): δ 7.40−
7.28 (m, 5H), 6.14−6.07 (m, 2H), 5.72 (dd, J = 11.8, 7.2 Hz, 1H),
5.33 (dd, J = 2.2, 0.6 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 4.44 (d, J =
12.0 Hz, 1H), 3.82 (ddd, J = 7.3, 3.1, 0.7 Hz, 1H), 3.68 (dd, J = 10.0,
1.9 Hz, 1H), 3.54−3.48 (m, 1H), 3.44 (s, 3H), 3.07 (d, J = 9.9 Hz,
1H), 3.03 (t, J = 6.6 Hz, 1H), 2.89 (dd, J = 9.3, 7.2 Hz, 1H), 2.74 (d, J
= 13.9 Hz, 1H), 1.87 (d, J = 5.7 Hz, 1H), 1.68 (dtd, J = 13.9, 6.9, 1.7
Hz, 1H), 1.52 (dd, J = 5.8, 1.8 Hz, 1H). 13C NMR (101 MHz,
CDCl3): δ 201.7, 147.6, 140.4, 138.3, 128.4, 127.7, 127.7, 127.1, 118.0,
82.7, 73.1, 70.5, 56.6, 52.7, 47.3, 45.6, 42.4, 42.0, 31.5, 22.4. HRMS
(ESI+): m/z calcd for C22H24NaO3 [M + Na]
+, 359.1618; found,
359.1617.
(1aR*,2R*,3aS*,4S*,6aS*,9S*)-1a-((Benzyloxy)methyl)-9-me-
thoxy-5-methylene-1a,2,3,3a,4,5-hexahydro-4,2-prop[1]-
enocyclopropa[c]pentalen-6(1H)-one (39a″). General procedure
starting from 4e and methanol. Reaction time: 1 h. Puriﬁcation:
cyclohexane/EtOAc 95/5 (eluted three times). White solid (9.7 mg,
yield 29%). Mp: 70−72 °C. 1H NMR (400 MHz, CDCl3): δ 7.40−
7.29 (m, 5H), 5.92 (dd, J = 1.4, 0.7 Hz, 1H), 5.43 (ddt, J = 12.8, 4.7,
1.9 Hz, 1H), 5.34 (ddd, J = 12.9, 4.9, 0.9 Hz, 1H), 5.28 (dd, J = 1.3, 0.7
Hz, 1H), 4.60 (d, J = 11.9 Hz, 1H), 4.41 (d, J = 11.9 Hz, 1H), 3.90 (t, J
= 4.0 Hz, 1H), 3.60 (t, J = 6.3 Hz, 1H), 3.52 (dd, J = 10.4, 1.8 Hz,
1H), 3.38 (s, 3H), 3.17 (d, J = 10.4 Hz, 1H), 2.83 (dt, J = 8.0, 2.6 Hz,
1H), 2.76 (t, J = 7.4 Hz, 1H), 2.29 (d, J = 14.4 Hz, 1H), 1.77 (d, J =
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5.4 Hz, 1H), 1.68−1.61 (m, 1H), 1.34 (dd, J = 5.5, 1.7 Hz, 1H). 13C
NMR (101 MHz, CDCl3): δ 202.1, 149.7, 138.1, 131.5, 128.4, 127.9,
127.8, 124.1, 115.5, 78.2, 73.1, 69.3, 56.9, 47.5, 47.1, 44.8, 43.6, 43.2,
26.7, 21.0. HRMS (ESI+): m/z calcd for C22H24NaO3 [M + Na]
+,
359.1618; found, 359.1616.
(1aR*,2S*,3aS*,4S*,6aS*,7R*)-7-(Allyloxy)-1a-((benzyloxy)-
methyl)-5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]-
enocyclopropa[c]pentalen-6(1H)-one (39b′). General procedure
starting from 4e and allyl alcohol. Reaction time: 1.5 h. Puriﬁcation:
cyclohexane/EtOAc 95/5 (eluted three times). White solid (15.9 mg,
yield 44%). Mp: 44−46 °C. 1H NMR (400 MHz, CDCl3): δ 7.39−
7.28 (m, 5H), 6.13−6.07 (m, 2H), 5.98 (ddt, J = 17.2, 10.3, 5.6 Hz,
1H), 5.68 (dd, J = 11.7, 7.3 Hz, 1H), 5.34 (dq, J = 17.1, 1.4 Hz, 1H),
5.31−5.29 (m, 1H), 5.23 (dq, J = 10.4, 1.4 Hz, 1H), 4.58 (d, J = 11.9
Hz, 1H), 4.44 (d, J = 11.8 Hz, 1H), 4.15 (ddt, J = 12.6, 5.5, 1.5 Hz,
1H), 4.07 (ddt, J = 12.6, 5.7, 1.4 Hz, 1H), 3.97 (ddd, J = 7.3, 3.1, 0.6
Hz, 1H), 3.68 (dd, J = 10.0, 1.8 Hz, 1H), 3.50 (dq, J = 9.2, 2.5 Hz,
1H), 3.06 (d, J = 10.0 Hz, 1H), 3.06 (t, J = 6.7 Hz, 1H), 2.90 (dd, J =
9.3, 7.2 Hz, 1H), 2.80 (d, J = 13.9 Hz, 1H), 1.86 (d, J = 5.7 Hz, 1H),
1.69 (dtd, J = 13.9, 6.9, 1.7 Hz, 1H), 1.52 (dd, J = 5.7, 1.8 Hz, 1H). 13C
NMR (101 MHz, CDCl3): δ 201.7, 147.7, 140.3, 138.3, 135.1, 128.4,
127.7, 127.7, 127.3, 118.0, 117.2, 80.1, 73.1, 70.5, 69.7, 52.8, 47.3, 46.0,
42.4, 42.0, 31.6, 22.4. HRMS (ESI+): m/z calcd for C24H26NaO3 [M +
Na]+, 385.1774; found, 385.1780.
(1aR*,2R*,3aS*,4S*,6aS*,9S*)-9-(Allyloxy)-1a-((benzyloxy)-
methyl)-5-methylene-1a,2,3,3a,4,5-hexahydro-4,2-prop[1]-
enocyclopropa[c]pentalen-6(1H)-one (39b″). General procedure
starting from 4e and allyl alcohol. Reaction time: 1.5 h. Puriﬁcation:
cyclohexane/EtOAc 95/5 (eluted three times). White solid (15.1 mg,
yield 42%). Mp: 67−69 °C. 1H NMR (400 MHz, CDCl3): δ 7.39−
7.29 (m, 5H), 6.00−5.86 (m, 1H), 5.93−5.91 (m, 1H), 5.42 (ddt, J =
12.8, 4.6, 1.8 Hz, 1H), 5.37−5.31 (m, 1H), 5.29−5.27 (m, 1H), 5.28
(dq, J = 17.2, 1.6 Hz, 1H), 5.18 (dq, J = 10.3, 1.4 Hz, 1H), 4.57 (d, J =
11.8 Hz, 1H), 4.41 (d, J = 11.8 Hz, 1H), 4.13−4.04 (m, 2H), 3.99
(ddt, J = 12.8, 5.8, 1.4 Hz, 1H), 3.61 (t, J = 6.0 Hz, 1H), 3.52 (dd, J =
10.4, 1.8 Hz, 1H), 3.16 (d, J = 10.4 Hz, 1H), 2.84−2.79 (m, 1H), 2.77
(td, J = 7.1, 1.1 Hz, 1H), 2.36 (d, J = 14.4 Hz, 1H), 1.77 (d, J = 5.4 Hz,
1H), 1.71−1.59 (m, 1H), 1.33 (dd, J = 5.4, 1.7 Hz, 1H). 13C NMR
(101 MHz, CDCl3): δ 202.1, 149.7, 138.1, 135.1, 131.5, 128.4, 127.9,
127.7, 124.5, 117.0, 115.5, 76.0, 73.2, 70.2, 69.5, 47.4, 47.1, 44.9, 43.8,
43.6, 26.8, 21.0. HRMS (ESI+): m/z calcd for C24H26NaO3 [M +
Na]+, 385.1774; found, 385.1780.
(1aR*,2S*,3aS*,4S*,6aS*,7R*)-7-Hydroxy-1a-(methoxymethyl)-
5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]enocyclopropa-
[c]pentalen-6(1H)-one (39c′) and (1aR*,2R*,3aS*,4S*,6aS*,9S*)-9-
hydroxy-1a-(methoxymethyl)-5-methylene-1a,2,3,3a,4,5-hexahy-
dro-4,2-prop[1]enocyclopropa[c]pentalen-6(1H)-one (39c″). Gener-
al procedure starting from 4d and water. Reaction time: 3 h.
Puriﬁcation: cyclohexane/EtOAc 6/4 (eluted twice). Colorless oil
(15.5 mg, yield 63%). 39c′:39c″ = 1:2. 1H NMR (400 MHz, CDCl3):
39c′, δ 6.17 (ddd, J = 11.6, 6.8, 1.6 Hz, 1H), 6.11 (dd, J = 2.5, 0.6 Hz,
1H), 5.82 (dd, J = 11.6, 7.3 Hz, 1H), 5.40−5.32 (m, 1H), 4.38 (dd, J =
7.3, 3.1 Hz, 1H), 3.59 (dd, J = 10.1, 1.9 Hz, 1H), 3.47 (dd, J = 9.3, 2.7
Hz, 1H), 3.35 (s, 3H), 3.05−2.91 (m, 2H), 2.93 (d, J = 10.1 Hz, 1H),
2.75 (d, J = 14.2 Hz, 1H), 1.86 (d, J = 5.7 Hz, 1H), 1.79−1.66 (m,
1H), 1.50 (dd, J = 5.8, 1.9 Hz, 1H); 39c″, δ 5.94 (dd, J = 1.4, 0.6 Hz,
1H), 5.49 (ddt, J = 12.7, 4.9, 2.0 Hz, 1H), 5.39−5.33 (m, 1H), 5.30
(dd, J = 1.4, 0.6 Hz, 1H), 4.57 (t, J = 4.1 Hz, 1H), 3.62 (t, J = 6.6 Hz,
1H), 3.45 (dd, J = 10.5, 1.8 Hz, 1H), 3.33 (s, 3H), 3.03 (d, J = 10.5 Hz,
1H), 2.79 (td, J = 7.2, 1.2 Hz, 1H), 2.67 (dt, J = 8.0, 2.7 Hz, 1H), 2.30
(d, J = 14.5 Hz, 1H), 1.76 (d, J = 5.5 Hz, 1H), 1.74−1.64 (m, 1H),
1.32 (dd, J = 5.5, 1.8 Hz, 1H). 13C NMR (101 MHz, CDCl3): 39c′ +
39c″, δ 202.0, 201.6, 149.4, 147.5, 139.8, 131.2, 129.2, 126.0, 118.4,
115.7, 74.5, 72.8, 71.7, 69.0, 58.9, 58.8, 52.3, 48.2, 47.4, 47.2, 46.7,
44.7, 43.5, 42.3, 41.9, 32.1, 29.7, 26.4, 21.9, 20.9. HRMS (ESI+): m/z
calcd for C15H18NaO3 [M + Na]
+, 269.1148; found, 269.1139.
(1aR*,2S*,3aS*,4S*,6aS*,7R*)-1a-((Benzyloxy)methyl)-7-hy-
droxy-5-methylene-1a,2,3,3a,4,5-hexahydro-2,4-prop[1]-
enocyclopropa[c]pentalen-6(1H)-one (39d′) and (1aR*,2R*,3aS*,4-
S*,6aS*,9S*)-1a-((benzyloxy)methyl)-9-hydroxy-5-methylene-
1a,2,3,3a,4,5-hexahydro-4,2-prop[1]enocyclopropa[c]pentalen-
6(1H)-one (39d″). General procedure starting from 4e and water.
Reaction time: 5 h. Puriﬁcation: cyclohexane/EtOAc 6/4 (eluted
twice). Colorless oil (18.6 mg, yield 58%). 39d′:39d″ = 1:4. 1H NMR
(500 MHz, CDCl3): 39d′ δ 7.38−7.31 (m, 5H), 6.10 (dd, J = 2.5, 0.6
Hz, 1H), 6.08 (ddd, J = 11.6, 6.9, 1.6 Hz, 1H), 5.76 (dd, J = 11.7, 7.3
Hz, 1H), 5.38−5.31 (m, 1H), 4.56 (d, J = 11.9 Hz, 1H), 4.44 (d, J =
11.9 Hz, 1H), 4.38−4.34 (m, 1H), 3.68 (dd, J = 10.0, 1.8 Hz, 1H),
3.47 (dq, J = 9.2, 2.1 Hz, 1H), 3.08 (d, J = 9.8 Hz, 1H), 3.05 (d, J = 6.7
Hz, 1H), 2.96 (dd, J = 9.1, 7.2 Hz, 1H), 2.74 (d, J = 14.1 Hz, 1H), 1.87
(d, J = 5.8 Hz, 1H), 1.79−1.74 (m, 1H), 1.52 (dd, J = 5.7, 1.8 Hz, 1H);
39d″, δ 7.39−7.29 (m, 6H), 5.94 (dd, J = 1.4, 0.6 Hz, 1H), 5.42 (ddt, J
= 12.7, 4.7, 1.9 Hz, 1H), 5.34 (ddt, J = 12.7, 5.2, 0.9 Hz, 1H), 5.29 (dd,
J = 1.3, 0.6 Hz, 1H), 4.55 (d, J = 12.0 Hz, 1H), 4.52 (s, 1H), 4.43 (d, J
= 11.8 Hz, 1H), 3.64−3.59 (m, 1H), 3.53 (dd, J = 10.5, 1.7 Hz, 1H),
3.20 (d, J = 10.5 Hz, 1H), 2.82−2.77 (m, 1H), 2.73−2.69 (m, 1H),
2.29 (d, J = 14.5 Hz, 1H), 1.77 (d, J = 5.4 Hz, 1H), 1.69 (dddd, J =
14.8, 8.3, 7.1, 1.5 Hz, 1H), 1.34 (dd, J = 5.5, 1.7 Hz, 1H). 13C NMR
(126 MHz, CDCl3): 39d′ + 39d″, δ 201.9, 149.4, 139.9, 138.0, 131.1,
129.8, 128.4, 128.4, 127.8, 127.74, 127.7, 127.7, 127.7, 126.1, 118.3,
115.7, 74.5, 73.2, 73.1, 70.5, 69.5, 69.1, 52.5, 48.2, 47.4, 47.3, 46.8,
45.0, 43.5, 42.4, 42.0, 32.1, 26.4, 22.1, 21.0 (2 peaks missing due to
overlapping). HRMS (ESI+): m/z calcd for C21H22NaO3 [M + Na]
+,
345.1461; found, 345.1459.
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